Used in research settings as a selective inhibitor of the MDM2-p53 protein-protein interaction, helping to activate p53 in cancer cells. This compound is investigated for its potential in oncology drug development, particularly in tumors where p53 is wild-type but suppressed by MDM2 overexpression. It serves as a tool compound to study apoptosis induction and cell cycle arrest in preclinical models.